Credit Trends: U.S. Composite Credit Spreads Daily (May 4, 2011)

  • ID: 1770863
  • Region: United States
  • Standard & Poors
1 of 2

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Commentary
Criteria articles describe the thought process and methodology Standard & Poor's analysts use in determining ratings. These commentary pieces discuss both the quantitative (economic and financial) and qualitative (business analysis and caliber of management) aspects of the analysis, as well as legal issues.

Standard & Poor's investment-grade composite spread tightened to 161 basis points (bps) on Tuesday, while the speculative-grade composite spread expanded by one basis point to 482 bps. By rating, the 'AA' spread contracted by one basis point to 111 bps, and the 'A' and 'BBB' spreads were unchanged at 143 bps and 192 bps, respectively. The 'BB' spread widened by one basis point to 349 bps, 'B' expanded by 2 bps to 509 bps, and 'CCC' tightened by 2 bps to 722 bps. By industry, financial institutions and industrials each contracted by one basis point, to 245 bps and 243 bps, respectively. Utilities and telecommunications were unchanged at 170 bps and 255 bps, respectively. Banks tightened by 2 bps to...

Note: Product cover images may vary from those shown
2 of 2
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.